Life
Sciences
We provide timely and accurate drug development and commercialization services from our U.S. owned and operated CDMO/CRO network.
improving our health
We believe the therapies our customers develop are critical to improving lives and we are proud to be a part.
Addressing the Complexity of Modern Therapeutics – Dr. Frank Tagliaferri, Pace® Life Sciences
The modern therapeutic landscape is defined by an ever-growing portfolio of complex drug products – from biologics and gene therapies to mRNA-based vaccines and monoclonal antibodies.
Pace® Life Sciences to Expand Large Molecule Development, Manufacturing, and Analytical Testing Capacity in 2025
Company expands sterile fill-finish services, capacity for biologics development and manufacturing, and more.
Pace® Life Sciences Expands Capacity and Capability with Acquisition of Catalent’s
Analytical Services Laboratory in Research Triangle Park
Company broadens service offerings and strengthens network by purchasing Catalent’s Center-of-Excellence for Small Molecule Analytical Services facility in North Carolina
Pace® Life Sciences Announces Compliant US FDA Inspection of Operations in Oakdale, MN
Lou Forcellini, Head of Quality Assurance at Pace® Life Sciences shared, “The latest successful inspection of our Oakdale central laboratory further underscores our steadfast quality leadership, the expertise of our laboratory professionals…
Explore our range of services
Wherever you are in your drug development journey, we can help.
CRO/
CDMO
GMP
TESTING
MEDICAL
DEVICE
PROFESSIONAL
SERVICES
Learn More About us
Contact Us
Virtual Lab Tour
Take a tour through one of our
state-of-the-art Life Sciences
laboratories.
Submit A Sample
Learn more about submitting your
samples and our commitment to
quality at each step.
THE RIGHT PARTNER FOR YOUR PROJECT
We have a nationwide network of state-of-the-art facilities, each with long-established histories of successful product development and commercialization and excellent audit outcomes from regulatory agency and client reviews.
FDA
REGISTERED
DEA
DEA Schedules I – V
GMP
COMPLIANT
ISO
17025 ACCREDITED
OUR PROMISE TO YOU
We honor our commitments so you can honor yours™. Our investment in state-of-the-art facilities and highly trained experts emphasizes our commitment to delivering positive customer experiences across all phases of pharmaceutical and biopharmaceutical development.
- RELIABLE DELIVERY
- COLLABORATIVE RELATIONSHIPS
- EXCEPTIONAL SERVICE
IT ALL STARTED IN 2006
Since 2006, Pace® Life Sciences has continued to prioritize strategic investments and domestic acquisitions to meet the changing needs of our customers. As the market changes, we are committed to making sure we are positioned as the best U.S. owned and operated end-to-end solution for your program.
Conferences
INTERPHEX 2025
The leading global pharmaceutical and biotechnology event that fuses industry innovation with expert-led conference.
April 1-3, 2025 | Javits Center, NYC
feature webinar
Overview of FDA’s Expedited Programs for Serious Condition
Recognize the importance of expedited review programs, such as FTD, BTD, and RMAT Designation, and their impact on reducing drug development time.
Now available on demand
blog
Keeping Pace® with Pharma
Subscribe to our blog to follow the latest news in Life Sciences.